Dosing strategies for MLN8054, a selective Aurora A kinase inhibitor, based on pharmacokinetic modeling and simulations

  1. Lee, Y.
  2. Eton, O.
  3. Pappas, J.
  4. Chen, S.
  5. Paton, M.
  6. Dees, E. C.
  7. Jones, S.
  8. Cohen, R. B.
  9. Cervantes, A.
  10. Tabernero, J.
Aldizkaria:
EJC SUPPLEMENTS

ISSN: 1359-6349

Argitalpen urtea: 2008

Alea: 6

Zenbakia: 12

Orrialdeak: 130-131

Biltzarra: 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Mota: Biltzar ekarpena

DOI: 10.1016/S1359-6349(08)72349-8 GOOGLE SCHOLAR
Datuen iturria: WoS